Pramana Pharmaceuticals Inc., a biotechnology company developing a first in class oral treatment to restore systemic metabolic resilience, today announced that internationally renowned ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

Adults with insulin-deficient type 2 diabetes had a decrease in HbA1c that was maintained for 1 year after receiving a ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular ...

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one ...

As deaths from diabetes start to rival those from infectious threats like malaria, a new form of the condition linked to ...

PITTSBURGH (KDKA) — A popular diabetes medication will be in short supply for much longer than previously expected. Now, pharmacists and Pittsburgh-area patients like Mark Allen are scrambling. Allen ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

A study has found that diabetes threatens brain health, increasing the risk of dementia. The research team from the ...

News 8 On Your Side is investigating a critical drug shortage frustrating diabetics who need the medicine.Investigator Susan Shapiro looked into the shortage and what the drug maker had to say about ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes. Weight ...